HomeCUE • NASDAQ
add
Cue Biopharma Inc
Previous close
$0.26
Day range
$0.24 - $0.26
Year range
$0.23 - $1.05
Market cap
26.24M USD
Avg Volume
1.65M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 21.94M | 1,292.26% |
Operating expense | 21.74M | 1,429.84% |
Net income | 1.58M | 116.69% |
Net profit margin | 7.22 | 101.20% |
Earnings per share | — | — |
EBITDA | 2.64M | 127.66% |
Effective tax rate | 23.98% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 28.23M | 20.70% |
Total assets | 42.21M | 31.13% |
Total liabilities | 15.78M | 7.41% |
Total equity | 26.43M | — |
Shares outstanding | 97.66M | — |
Price to book | 0.98 | — |
Return on assets | 13.26% | — |
Return on capital | 19.56% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 1.58M | 116.69% |
Cash from operations | -1.08M | 88.08% |
Cash from investing | 7.02M | 702,100.00% |
Cash from financing | 9.49M | 1,118.45% |
Net change in cash | 15.44M | 254.96% |
Free cash flow | -6.06M | -72.01% |
About
Founded
2014
Headquarters
Website
Employees
29
